According to God of Prompt on X, Medvi’s so-called AI-powered, two-person, $1.8B run-rate story is primarily a lead-generation engine for GLP-1 prescriptions where the AI stack built the funnel, not the clinical or logistics backbone (source: God of Prompt). As reported by Polymarket on X, Medvi was built with $20,000 and two employees and is tracking toward $1.8 billion in annual sales, while current revenue cited in the thread is $401 million, highlighting demand-led growth in the GLP-1 market (source: Polymarket, God of Prompt). According to the post, core operations—including licensed telemedicine, pharmacy dispensing, and pharmaceutical supply chains—remain regulated and human-led, meaning LLMs cannot replace medical licensing, FDA compliance, or physical drug logistics (source: God of Prompt). The business implication is that AI delivers high ROI in marketing, customer support, and rapid content and A/B testing for telehealth lead gen, but defensibility and risk still hinge on clinician networks, compliance readiness, and supply partnerships—factors likely to face scrutiny if regulators tighten telehealth GLP-1 prescribing (source: God of Prompt).